237 related articles for article (PubMed ID: 15774615)
1. The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy.
Whitman SP; Liu S; Vukosavljevic T; Rush LJ; Yu L; Liu C; Klisovic MI; Maharry K; Guimond M; Strout MP; Becknell B; Dorrance A; Klisovic RB; Plass C; Bloomfield CD; Marcucci G; Caligiuri MA
Blood; 2005 Jul; 106(1):345-52. PubMed ID: 15774615
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm.
Döhner K; Tobis K; Ulrich R; Fröhling S; Benner A; Schlenk RF; Döhner H
J Clin Oncol; 2002 Aug; 20(15):3254-61. PubMed ID: 12149299
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia.
Steudel C; Wermke M; Schaich M; Schäkel U; Illmer T; Ehninger G; Thiede C
Genes Chromosomes Cancer; 2003 Jul; 37(3):237-51. PubMed ID: 12759922
[TBL] [Abstract][Full Text] [Related]
4. Mll partial tandem duplication and Flt3 internal tandem duplication in a double knock-in mouse recapitulates features of counterpart human acute myeloid leukemias.
Zorko NA; Bernot KM; Whitman SP; Siebenaler RF; Ahmed EH; Marcucci GG; Yanes DA; McConnell KK; Mao C; Kalu C; Zhang X; Jarjoura D; Dorrance AM; Heerema NA; Lee BH; Huang G; Marcucci G; Caligiuri MA
Blood; 2012 Aug; 120(5):1130-6. PubMed ID: 22674806
[TBL] [Abstract][Full Text] [Related]
5. Clinical and biological implications of partial tandem duplication of the MLL gene in acute myeloid leukemia without chromosomal abnormalities at 11q23.
Shiah HS; Kuo YY; Tang JL; Huang SY; Yao M; Tsay W; Chen YC; Wang CH; Shen MC; Lin DT; Lin KH; Tien HF
Leukemia; 2002 Feb; 16(2):196-202. PubMed ID: 11840285
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells.
Muñoz L; Nomdedéu JF; Villamor N; Guardia R; Colomer D; Ribera JM; Torres JP; Berlanga JJ; Fernández C; Llorente A; Queipo de Llano MP; Sánchez JM; Brunet S; Sierra J;
Leukemia; 2003 Jan; 17(1):76-82. PubMed ID: 12529663
[TBL] [Abstract][Full Text] [Related]
7. Delineation and molecular characterization of acute myeloid leukemia patients with coduplication of FLT3 and MLL.
Olesen LH; Nyvold CG; Aggerholm A; Nørgaard JM; Guldberg P; Hokland P
Eur J Haematol; 2005 Sep; 75(3):185-92. PubMed ID: 16104873
[TBL] [Abstract][Full Text] [Related]
8. The MLL partial tandem duplication in acute myeloid leukaemia.
Basecke J; Whelan JT; Griesinger F; Bertrand FE
Br J Haematol; 2006 Nov; 135(4):438-49. PubMed ID: 16965385
[TBL] [Abstract][Full Text] [Related]
9. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia.
Super HG; Strissel PL; Sobulo OM; Burian D; Reshmi SC; Roe B; Zeleznik-Le NJ; Diaz MO; Rowley JD
Genes Chromosomes Cancer; 1997 Oct; 20(2):185-95. PubMed ID: 9331569
[TBL] [Abstract][Full Text] [Related]
10. Internal tandem duplications of the FLT3 and MLL genes are mainly observed in atypical cases of therapy-related acute myeloid leukemia with a normal karyotype and are unrelated to type of previous therapy.
Christiansen DH; Pedersen-Bjergaard J
Leukemia; 2001 Dec; 15(12):1848-51. PubMed ID: 11753604
[TBL] [Abstract][Full Text] [Related]
11. The Mll partial tandem duplication: differential, tissue-specific activity in the presence or absence of the wild-type allele.
Dorrance AM; Liu S; Chong A; Pulley B; Nemer D; Guimond M; Yuan W; Chang D; Whitman SP; Marcucci G; Caligiuri MA
Blood; 2008 Sep; 112(6):2508-11. PubMed ID: 18617636
[TBL] [Abstract][Full Text] [Related]
12. Tandem duplications of MLL and FLT3 are correlated with poor prognoses in pediatric acute myeloid leukemia: a study of the Japanese childhood AML Cooperative Study Group.
Shimada A; Taki T; Tabuchi K; Taketani T; Hanada R; Tawa A; Tsuchida M; Horibe K; Tsukimoto I; Hayashi Y
Pediatr Blood Cancer; 2008 Feb; 50(2):264-9. PubMed ID: 17763464
[TBL] [Abstract][Full Text] [Related]
13. Detection of unique ALL1 (MLL) fusion transcripts in normal human bone marrow and blood: distinct origin of normal versus leukemic ALL1 fusion transcripts.
Marcucci G; Strout MP; Bloomfield CD; Caligiuri MA
Cancer Res; 1998 Feb; 58(4):790-3. PubMed ID: 9485036
[TBL] [Abstract][Full Text] [Related]
14. Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations.
Drexler HG; Quentmeier H; MacLeod RA
Leukemia; 2004 Feb; 18(2):227-32. PubMed ID: 14671638
[TBL] [Abstract][Full Text] [Related]
15. Mll partial tandem duplication induces aberrant Hox expression in vivo via specific epigenetic alterations.
Dorrance AM; Liu S; Yuan W; Becknell B; Arnoczky KJ; Guimond M; Strout MP; Feng L; Nakamura T; Yu L; Rush LJ; Weinstein M; Leone G; Wu L; Ferketich A; Whitman SP; Marcucci G; Caligiuri MA
J Clin Invest; 2006 Oct; 116(10):2707-16. PubMed ID: 16981007
[TBL] [Abstract][Full Text] [Related]
16. Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML.
Schnittger S; Kinkelin U; Schoch C; Heinecke A; Haase D; Haferlach T; Büchner T; Wörmann B; Hiddemann W; Griesinger F
Leukemia; 2000 May; 14(5):796-804. PubMed ID: 10803509
[TBL] [Abstract][Full Text] [Related]
17. Stress hematopoiesis reveals abnormal control of self-renewal, lineage bias, and myeloid differentiation in Mll partial tandem duplication (Mll-PTD) hematopoietic stem/progenitor cells.
Zhang Y; Yan X; Sashida G; Zhao X; Rao Y; Goyama S; Whitman SP; Zorko N; Bernot K; Conway RM; Witte D; Wang QF; Tenen DG; Xiao Z; Marcucci G; Mulloy JC; Grimes HL; Caligiuri MA; Huang G
Blood; 2012 Aug; 120(5):1118-29. PubMed ID: 22740449
[TBL] [Abstract][Full Text] [Related]
18. FLT3 and MLL intragenic abnormalities in AML reflect a common category of genotoxic stress.
Libura M; Asnafi V; Tu A; Delabesse E; Tigaud I; Cymbalista F; Bennaceur-Griscelli A; Villarese P; Solbu G; Hagemeijer A; Beldjord K; Hermine O; Macintyre E
Blood; 2003 Sep; 102(6):2198-204. PubMed ID: 12791658
[TBL] [Abstract][Full Text] [Related]
19. Eradicating acute myeloid leukemia in a Mll(PTD/wt):Flt3(ITD/wt) murine model: a path to novel therapeutic approaches for human disease.
Bernot KM; Nemer JS; Santhanam R; Liu S; Zorko NA; Whitman SP; Dickerson KE; Zhang M; Yang X; McConnell KK; Ahmed EH; Muñoz MR; Siebenaler RF; Marcucci GG; Mundy-Bosse BL; Brook DL; Garman S; Dorrance AM; Zhang X; Zhang J; Lee RJ; Blum W; Caligiuri MA; Marcucci G
Blood; 2013 Nov; 122(23):3778-83. PubMed ID: 24085765
[TBL] [Abstract][Full Text] [Related]
20. Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B study.
Whitman SP; Ruppert AS; Marcucci G; Mrózek K; Paschka P; Langer C; Baldus CD; Wen J; Vukosavljevic T; Powell BL; Carroll AJ; Kolitz JE; Larson RA; Caligiuri MA; Bloomfield CD
Blood; 2007 Jun; 109(12):5164-7. PubMed ID: 17341662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]